NGL Fine Chem Ltd

₹ 1,587 -4.10%
18 Aug - close price
About

Established in 1981, NGL Fine-Chem Limited manufacturers and markets APIs, Intermediates and Finished Dosage forms for human and animal pharmaceutical product. It caters to various Indian and global companies with high quality and reliable products. [1]

Key Points

Product Portfolio
Presently, Veterinary APIs is the main product of the company which account for 89% of its revenues, followed by Veterinary Formulations (5%), Human APIs (2%), Intermediates (2%) & Others (2%). [1] The company has been able to increase its market share in the lower share of its portfolio which has increased to the levels of 50-60%. [2]

  • Market Cap 981 Cr.
  • Current Price 1,587
  • High / Low 3,435 / 1,498
  • Stock P/E 31.4
  • Book Value 329
  • Dividend Yield 0.11 %
  • ROCE 33.9 %
  • ROE 27.9 %
  • Face Value 5.00

Pros

  • Company has a good return on equity (ROE) track record: 3 Years ROE 29.0%

Cons

  • Earnings include an other income of Rs.14.4 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022
40.70 37.21 37.42 35.44 42.31 68.34 72.72 71.77 75.86 78.37 81.14 84.06 64.61
32.25 32.90 34.19 33.15 28.89 47.94 50.32 50.98 52.29 61.21 68.64 73.50 63.10
Operating Profit 8.45 4.31 3.23 2.29 13.42 20.40 22.40 20.79 23.57 17.16 12.50 10.56 1.51
OPM % 20.76% 11.58% 8.63% 6.46% 31.72% 29.85% 30.80% 28.97% 31.07% 21.90% 15.41% 12.56% 2.34%
1.35 0.98 1.19 0.83 2.19 2.76 3.51 2.30 4.55 4.39 3.84 2.98 3.14
Interest 0.48 0.58 0.64 0.60 0.60 0.54 0.37 0.33 0.37 0.40 0.42 1.54 0.50
Depreciation 1.87 1.97 2.07 2.21 2.10 2.05 2.11 2.08 2.18 2.20 2.42 3.48 3.60
Profit before tax 7.45 2.74 1.71 0.31 12.91 20.57 23.43 20.68 25.57 18.95 13.50 8.52 0.55
Tax % 30.34% 14.23% 34.50% 164.52% 27.42% 23.19% 24.41% 33.08% 25.22% 26.65% 26.30% 19.60% 5.45%
Net Profit 5.20 2.35 1.13 -0.20 9.37 15.81 17.71 13.84 19.13 13.91 9.95 6.87 0.52
EPS in Rs 8.42 3.80 1.83 -0.32 15.17 25.59 28.67 22.40 30.96 22.52 16.11 11.12 0.84

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 TTM
153 152 258 318 308
121 130 178 249 266
Operating Profit 32 22 80 68 42
OPM % 21% 14% 31% 21% 14%
4 1 8 11 14
Interest 3 3 2 2 3
Depreciation 6 8 8 10 12
Profit before tax 28 12 78 67 42
Tax % 27% 31% 27% 25%
Net Profit 20 8 57 50 31
EPS in Rs 32.58 13.50 91.81 80.77 50.59
Dividend Payout % 5% 13% 2% 2%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 28%
TTM: 7%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 35%
TTM: -53%
Stock Price CAGR
10 Years: 61%
5 Years: 32%
3 Years: 47%
1 Year: -49%
Return on Equity
10 Years: %
5 Years: %
3 Years: 29%
Last Year: 28%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022
3 3 3 3
Reserves 89 96 151 200
27 28 16 30
23 26 36 44
Total Liabilities 142 154 207 277
61 68 64 89
CWIP -0 -0 12 6
Investments 9 11 29 29
73 75 102 153
Total Assets 142 154 207 277

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022
9 20 27 14
-10 -20 -25 -14
-0 -1 -1 -1
Net Cash Flow -1 -0 2 -1

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022
Debtor Days 79 63 53 74
Inventory Days 106 155 132 137
Days Payable 88 108 86 82
Cash Conversion Cycle 97 110 99 128
Working Capital Days 107 93 76 117
ROCE % 14% 54% 34%

Shareholding Pattern

Numbers in percentages

Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022
73.83 73.83 73.81 73.81 73.81 73.81 73.81 73.81 73.81 73.81 73.81 73.81
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.05
0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
26.17 26.16 26.19 26.19 26.19 26.19 26.19 26.19 26.19 26.19 26.18 26.14

Documents

Concalls